| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454446 | Lung Cancer | 2017 | 27 Pages |
Abstract
In NSCLC patients, the confirmed ORR to single-agent chemotherapy after immunotherapy exposure was higher as compared to historical data from the pre-anti-PD1 era, and approached ORR to first-line platinum-based chemotherapy. Further investigation of a possible immunotherapy-induced chemosensitization effect is warranted.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gustavo Schvartsman, S. Andrew Peng, Giorgios Bis, J. Jack Lee, Marcelo F.K. Benveniste, Jianjun Zhang, Emily B. Roarty, Lara Lacerda, Stephen Swisher, John V. Heymach, Frank V. Fossella, William N. William,